| Name | Title | Contact Details |
|---|
We empower the most underserved stakeholder in the healthcare system – the family caregiver. While training programs exist for home health aides or nurses to help manage care of the elderly, family members, who provide 80%+ of care to loved ones aging-in-place, have limited access to training. For example, actionable education like how to prevent falls in the house, safely transfer from a bed or chair, or manage difficult behaviour when a loved one has dementia. Recognizing that this content exists but isn`t available to families, Trualta adapted professional-level healthcare training for the family member audience. We deliver the training via an informal and interactive online learning environment, and tailor the learning to each caregiver`s situation. The program incentivizes engagement with a rewards system, and users can redeem rewards for helpful products and services. Our customers, healthcare payers and providers in Canada & the US, offer Trualta at point-of-care to better enable families to transition aging loved ones from hospital to home, and sustain independent living. Through clinical validation studies in the US and Canada, we are linking participation in Trualta`s program to improved outcomes and reduced costs. We are a proud resident company of the Biomedical Zone in downtown Toronto and the Invest Ottawa Accelerator program. If you are passionate about educating and enabling families to improve care for our aging population, drop us a note at info@trualta.com – we`d love to hear from you.
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with the information they need to make choices about their health.
Lexicomm International, Ltd. is a Jenkintown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At the Y, our cause is strengthening the foundations of community.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.